Physician profile
Nicole N Harter
NPI 1780027102
$42,315.81
in general payments reported to CMS, 2019-2025
8 companies · $30K in 2025
The $30K reported for 2025 was more than what 92% of Pediatric Dermatology providers received nationally (typical 2025 total: $302).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $234 · 2024: $12K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Travel and Lodging: $2,632 · Food and Beverage: $2,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,406.00 |
| Travel and Lodging | $2,631.50 |
| Food and Beverage | $2,044.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $29,846.82 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $12,156.55 | 2022-2025 | Dupixent |
| Regeneron Pharmaceuticals, INC. | $100.97 | 2025 | Dupixent |
| Pfizer INC. | $91.65 | 2025 | |
| Lilly USA, LLC | $55.98 | 2025 | Ebglyss, Taltz |
| Lnhc, INC | $27.59 | 2025 | Zelsuvmi |
| Arcutis Biotherapeutics, INC. | $22.61 | 2025 | Zoryve |
| Galderma Laboratories, L.P. | $13.64 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Harter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.